Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

TEMSIROLIMUS

TEMSIROLIMUS

Standard Dose
25MG/ML (25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TEMSIROLIMUS is listed in Drugs@FDA under application 207383 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TEMSIROLIMUS Form and strength SOLUTION;INTRAVENOUS - 25MG/ML (25MG/ML) Sponsor GLAND Submission history Latest submission status date: 2019-08-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview TEMSIROLIMUS is listed in Drugs@FDA under application 207383 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient TEMSIROLIMUS Form and strength SOLUTION;INTRAVENOUS - 25MG/ML (25MG/ML) Sponsor GLAND Submission history Latest submission status date: 2019-08-16 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.